Superficial-vein thrombosis

From Ganfyd

Jump to: navigation, search

Superficial thrombophlebitis was a condition with out licensed drug treatment until 2010 when fondaparinux for 45 days showed a reduction in complicating VTE events of 1%. This is very similar to the risk patients face at the end of current treatment regimes for first ever VTE events[1]. It is possible that the insufficiently studied out of license use of NSAIDs and other usual treatments is more cost effective[2][3]. Surgical intervention is sometimes used. There are associations such as with Behçet's syndrome or the migratory non varicose vein thrombophlebitis form associated with malignancy. Short courses of low molecular weight heparin are useless[4].

This article is a work in progress. Please feel free to contribute to it.


References

Personal tools